Subscribe To
Trevena Announces Approval of OLINVYK in China
Trevena’s partner, Jiangsu Nhwa, receives approval from Chinese National Medical Products Administration (NMPA) Approval achieves $3 million milestone to Trevena from Jiangsu Nhwa Additional $15 million to Trevena expected on first commercial sale in China, based on ex-US Royalty-Based Financing with R-Bridge Healthcare Fund, an affiliate of CBC Group CHESTERBROOK, Pa., May 08, 2023 (GLOBE […] The post Trevena Announces Approval of OLINVYK in China appeared first on ForexTV...
Read More
Posted: May 8 2023, 11:00
Author Name: forextv
Views: 081885